An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: Limitations in patients with mild and/or episodic hypercortisolism

Experimental and Clinical Endocrinology and Diabetes

Volumn 114, Issue 7, 2006, Pages 356-360

  Friedman, Theodore C ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Cushing's Syndrome; Dexamethasone; Episodic; Hypercortisolism; Periodic

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; LABORATORY TEST; PRIORITY JOURNAL; SCREENING TEST;

ADOLESCENT; ADULT; BODY MASS INDEX; CUSHING SYNDROME; DEXAMETHASONE; HUMANS; HYDROCORTISONE; MIDDLE AGED;

EID: 33747613314     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924281     Document Type: Article

References (28)

1. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 2003; 88: 5593-5602
2. Asfeldt VH. Simplified dexamethasone suppression test. Acta Endocrinol (Copenh) 1969; 61: 219-231
3. Blethen SL, Chasalow FI. Overnight dexamethasone suppression test: normal responses and the diagnosis of Cushing's syndrome. Steroids 1989; 54: 185-193
4. Connolly CK, Gore MB, Stanley N, Wills MR. Single-dose dexamethasone suppression in normal subjects and hospital patients. Br Med J 1968; 2: 665-667
5. Crapo LM. Cushing's syndrome: a review of diagnostic tests. Metab 1979; 28: 955-977
6. Cronin C, Igoe D, Duffy MJ, Cunningham SK, McKenna TJ. The overnight dexamethasone test is a worthwhile screening procedure. Clin Endocrinol (Oxf) 1990; 33: 27-33
7. Findling JW, Raff H, Aron DC. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome. J Clin Endocrinol Metab 2004; 89: 1222-1226
8. Foster LB, Dunn RT. Single-antibody technique for radioimmunoassay of cortisol in unextracted serum or plasma. Clin Chem 1974; 20: 365-368
9. Friedman TC. Pseudo-Cushing syndrome. In: Margioris AN, Chrousos GP (eds.) Contemporary Endocrinology: Adrenal Disorders. Totowa, NJ: Humana Press, 2001: 203-218
10. Friedman TC. The adrenal gland. In: Andreoli TE, Carpenter CCJ, Griggs RC, Loscalzo J (eds.) Cecil Essentials of Medicine, 6th ed. Philadelphia: W. B. Saunders Company, 2004: 603-614
11. Holdaway IM, Evans MC, Ibbertson HK. Experience with a short test of pituitary-adrenal function. Aust N Z J Med 1973; 3: 507-511
12. Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 2003; 88: 5299-5306
13. Liddle GW. Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 1960; 20: 1539-1561
14. McHardy-Young S, Harris PW, Lessof MH, Lyne C. Single dose dexamethasone suppression test for Cushing's Syndrome. Br Med J 1967; 2: 740-744
15. Mendlewicz J, Charles G, Franckson JM. The dexamethasone suppression test in affective disorder: relationship to clinical and genetic subgroups. Br J Psychiatry 1982; 141: 464-470
16. Montwill J, Igoe D, McKenna TJ. The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome. Steroids 1994; 59: 296-298
17. Nugent CA, Nichols T, Tyler FH. Diagnosis of Cushing's syndrome: single dose dexamethasone suppression test. Arch Intern Med 1965; 116: 172-176
18. Papanicolaou DA, Yanovski JA, Cutler G, Jr., Chrousos GP, Nieman LK. A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. J Clin Endocrinol Metab 1998; 83: 1163-1167
19. Pavlatos FC, Smilo RP, Forsham PH. A rapid screening test for Cushing's syndrome. JAMA 1965; 193: 720-723
20. Raff H, Raff JL, Findling JW. Late-night salivary cortisol as a screening test for Cushing's syndrome. J Clin Endocrinol Metab 1998; 83: 2681-2686
21. Seidensticker JF, Folk RL, Wieland RG, Hamwi GJ. Screening test for Cushing's syndrome with plasma 11-hydroxycorticosteroids. JAMA 1967;202:87-90
22. Silber RH, Porter CC. The determination of 17, 21-dihydroxy-20- ketosteroids in urine and plasma. J Biol Chem 1954; 210: 923
23. Stewart PM. The adrenal cortex. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds) Williams Textbook of Endocrinology, 10th ed. Philadelphia: Saunders, 2003: 491-551
24. Thoren M, Sjoberg HE, Hall K, Low H. A rapid screening test for Cushing's syndrome. Acta Med Scand 1975; 198: 303-308
25. Tucci JR, Jagger PI, Lauler DP, Thorn GW. Rapid dexamethasone suppression test for Cushing's syndrome. JAMA 1967; 199: 379-382
26. Williams GH, Dhuly RG. Disorders of the adrenal cortex. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds) Harrison's Principles of Internal Medicine, 15th ed. New York: McGraw-Hill, 2001: 2084-2105
27. Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B. Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome-recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 1997; 34: 222-229
28. Yanovski JA, Cutler GB, Jr., Chrousos GP, Nieman LK. Corticotropin- releasing hormone stimulation following low-dose dexamethasone administration: A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. J Am Med Assoc 1993; 269: 2232-2238